Natural Immunity much more Effective than Pfizer Vaccine, Comirnaty up to 13 times more effective.. Vaccinated people were 27x more likely to be symptomatic.
In the study which involved 2.5 million participants Israelis who were at any time infected with Covid-19 had more protection against the Delta variant than those who had a covid shot be it Pfizer, Moderna, Astrazeneca, fully vaccinated or not.
After telling Americans that vaccines offer better protection than natural infection, a new study out of Israel shows the opposite is true that natural immunity is a much better deterrent to the delta variant than vaccines.
The new analysis relies on the database of Maccabi Healthcare Services, which enrolls about 2.5 million Israelis. The study, led by Tal Patalon and Sivan Gazit at KSM, the system’s research and innovation arm, found in two analyses that people who were vaccinated in January and February were, in June, July, and the first half of August, six to 13 times more likely to get infected than unvaccinated people who were previously infected with the coronavirus. In one analysis, comparing more than 32,000 people in the health system, the risk of developing symptomatic COVID-19 was 27 times higher among the vaccinated, and the risk of hospitalization eight times higher.
The proof is overwhelming: natural infection truly is the best protection against delta, however Key American agencies and government officials still won’t even acknowledge that the already infected have antibodies protecting them from the virus.
As the first country to achieve widespread coverage by the vaccine, Israel is now in an unthinkable situation: daily case numbers have reached new record levels.
“This analysis demonstrated that natural immunity affords longer lasting and stronger protection against infection, symptomatic disease and hospitalization due to the delta variant,” the researchers said.
The study also showed that protection offered by natural infection wanes over time, just like the protection afforded by vaccines. The risk of a vaccine-breakthrough delta case was thirteen times higher than the risk of developing a second infection when the original illness occurred 4+ months prior.